Using disproportionality analysis to explore the association between periostitis and triazole antifungals in the fda adverse event reporting system database

HIGHLIGHTS

• who: Hailong Li from the Department of Pharmacy, West China Second University have published the article: Using disproportionality analysis to explore the association between periostitis and triazole antifungals in the FDA Adverse Event Reporting System Database, in the Journal: Scientific Reports Scientific Reports

SUMMARY

Characteristics of patients taking triazole antifungals and experiencing periostitis. There were 4 patients (2.80%) aged less than 18 years, 87 patients (60.84%) aged 18-65 years, and 31 patients (21.68%) aged more than 65 years. The study observed 143 patients with adverse event reports of voriconazole . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.